Foghorn Therapeutics, Inc. (FHTX)
5.29
+0.43
(+8.85%)
USD |
NASDAQ |
Apr 17, 16:00
5.27
-0.02
(-0.38%)
After-Hours: 20:00
Foghorn Therapeutics EPS Diluted (Quarterly) : -0.3824 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Halozyme Therapeutics, Inc. | -1.203 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Verastem, Inc. | -0.3947 |
| Fortress Biotech, Inc. | -0.1976 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.66M |
| Revenue (Quarterly) | 9.247M |
| Total Expenses (Quarterly) | 30.91M |
| Enterprise Value | 191.65M |
| Gross Profit Margin (Quarterly) | 91.33% |
| Profit Margin (Quarterly) | -234.3% |
| Earnings Yield | -23.03% |
| Normalized Earnings Yield | -21.65 |